Search

Supplementary Figure 5 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Supplementary Figure Legends 1-5 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Supplementary Figure 3 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Supplementary Figure 1 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Supplementary Figure 6 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Supplementary Figure 4 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Vascular endothelial growth factor A (VEGFA) is a specific mitogen for vascular endothelial cells that plays a critical role in cancer neoangiogenesis. Here, we report that the nucleolar tumor suppressor p19ARF suppresses VEGFA expression, acting at the level of mRNA translation without affecting the transcription of the VEGFA gene. Translational repression of VEGFA mRNA by p19ARF does not require p53, a major target of the ARF tumor suppressor pathway, but instead correlates with binding to nucleophosmin/B23. Maintaining VEGFA expression relies on nucleophosmin/B23, and downregulating this protein by RNAi or p19ARF leads to translational repression of VEGFA. p19ARF inhibits VEGFA-dependent tumor angiogenesis in nude mice. Additionally, p14ARF expression and microvessel density are inversely correlated in human colon carcinomas. Taken together, our results define a mechanism by which the ARF tumor suppressor targets the translational repression of specific oncogenes during neoplastic transformation. Cancer Res; 70(11); 4749–58. ©2010 AACR.

Supplementary Figure 2 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA